🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
34.33
-0.06 (-0.17%)
Nov 18, 2026, 1:25 PM EST - Market open

LKFT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,2152,1661,8092,6942,9093,669
Market Cap Growth
7.41%19.74%-32.85%-7.39%-20.71%-43.02%
Enterprise Value
-245-1,406-1,635-1,503-1,728-1,844
Last Close Price
34.3932.7027.5040.6544.3855.13

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
3.465.7523.5911.51--
PS Ratio
1.961.666.3410.1711.2813.77
PB Ratio
0.600.570.600.871.081.22
P/TBV Ratio
0.770.570.660.941.171.24

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.010.01
Debt / EBITDA Ratio
0.010.01----
Net Debt / Equity Ratio
-0.68-0.92-1.07-1.31-1.61-1.77
Net Debt / EBITDA Ratio
-3.92-5.2620.2688.6162.1828.64
Net Debt / FCF Ratio
9.6511.039.228.657.718.38
Asset Turnover
0.280.300.070.050.050.04
Inventory Turnover
15.1613.285.923.807.3430.64
Quick Ratio
32.6519.969.578.767.988.53
Current Ratio
32.8420.159.979.028.118.58
Return on Equity (ROE)
20.12%10.42%-0.04%-0.15%-2.76%-4.55%
Return on Assets (ROA)
9.93%8.87%-2.75%-1.17%-1.65%-1.97%
Return on Invested Capital (ROIC)
87.08%218.72%----
Return on Capital Employed (ROCE)
17.40%16.50%-4.90%-2.20%-3.10%-3.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
28.90%17.39%4.24%8.69%-8.01%-3.20%
FCF Yield
-11.44%-14.70%-19.27%-17.42%-19.39%-17.29%
Buyback Yield / Dilution
-0.05%0.06%-0.01%-0.36%-0.30%-0.65%
SEC Filings: 10-K · 10-Q